Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy.
Montserrat Fernández-RivasAndrea VeredaBrian P VickeryVibha SharmaCaroline NilssonAntonella MuraroJonathan O'B HourihaneAudrey Dunn GalvinGeorge du ToitKatharina BlumchenKirsten BeyerAlex SmithRobert RyanDaniel C AdelmanStacie M JonesPublished in: Allergy (2021)
These results demonstrate that daily PTAH treatment for peanut allergy beyond 1 year leads to an improved safety/tolerability profile and continued clinical and immunological response.